1. Home
  2. EPSM vs QNME Comparison

EPSM vs QNME Comparison

Compare EPSM & QNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Epsium Enterprise Limited Ordinary Shares

EPSM

Epsium Enterprise Limited Ordinary Shares

N/A

Current Price

$0.83

Market Cap

12.3M

Sector

N/A

ML Signal

N/A

QNME

Quanome Technologies Inc. Common Stock

N/A

Current Price

$0.42

Market Cap

14.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
EPSM
QNME
Founded
2010
2018
Country
China
United States
Employees
N/A
N/A
Industry
Integrated Freight & Logistics
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
14.1M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
EPSM
QNME
Price
$0.83
$0.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
23.8K
★ 3.7M
Earning Date
11-24-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 47.83
EPS
★ N/A
N/A
Revenue
N/A
★ $5,850,681.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 111.79
52 Week Low
$0.77
$0.26
52 Week High
$10.19
$1.40

Technical Indicators

Market Signals
Indicator
EPSM
QNME
Relative Strength Index (RSI) 36.89 45.03
Support Level $0.83 $0.37
Resistance Level $1.64 $0.94
Average True Range (ATR) 0.08 0.05
MACD -0.00 -0.01
Stochastic Oscillator 32.76 25.81

Price Performance

Historical Comparison
EPSM
QNME

About EPSM Epsium Enterprise Limited Ordinary Shares

Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohols.

About QNME Quanome Technologies Inc. Common Stock

Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.

Share on Social Networks: